Pilaralisib, CAS [[934526-89-3]]

Produktübersicht

• Artikelname: Pilaralisib, CAS [[934526-89-3]]
• Artikelnummer: TGM-T2365
• Hersteller Artikelnummer: T2365
• Alternativnummer: TGM-T2365-1MLX10MM(INDMSO),TGM-T2365-2MG,TGM-T2365-5MG,TGM-T2365-10MG,TGM-T2365-25MG,TGM-T2365-50MG,TGM-T2365-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: SAR245408 , XL-147

Produktbeschreibung

Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.

Produkteigenschaften

• Molekulargewicht: 541.02
• Reinheit: 99.61%
• CAS Nummer: [934526-89-3]
• Formel: C25H25ClN6O4S
• Target-Kategorie: PI3K

Bilder

T2365